Summary of findings 1: Efficacy and safety of IVT lampalizumab 4‐weekly (monthly) vs sham
Change in visual acuity (logMAR) ‐ 12 months (negative is better) · adults with GA due to AMD
1 finding from 1 review
- no estimate extracted3 studies · 1182 participantsHigh